HT
ABEO icon

Headlands Technologies’s Abeona Therapeutics ABEO Stock Holding History

Headlands Technologies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
+63,345
New +$317K 0.03% 512

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Headlands Technologies's ABEO Position: Q1 2026 in Review

Headlands Technologies opened a new position in Abeona Therapeutics (ABEO) in Q1 2026: 63,345 shares worth $284K. The stake represents 0.03% of the portfolio and ranks #512 among its holdings.

108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Headlands Technologies held 63,345 shares of Abeona Therapeutics worth $284K as of Q1 2026.
  • Abeona Therapeutics was a new Headlands Technologies position in Q1 2026.
  • Abeona Therapeutics made up 0.03% of Headlands Technologies's portfolio in Q1 2026, its #512 holding.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.